Regular use of ivermectin led to a 100% reduction in hospitalisation rate, a 92% reduction in mortality rate and an 86% reduction in the risk of dying from a COVID-19 infection when compared to non-users, a major new study has found. The study, published in the medical journal Cureus, analysed data from 223,128 people from the city of Itajaí in Brazil and is the largest study of its kind, giving its findings a high degree of certainty. Senior author Dr. Flavio A. Cadegiani wrote on Twitter: “An observational study with the size and level of analysis as ours is hardly …read more
Source: Sott health news feed
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr